Dual Laplacian regularized matrix completion for microRNA-disease associations prediction. Issue 5 (4th May 2019)

• Record Type: Journal Article
• Authors: Tang, Chang; Zhou, Hua; Zheng, Xiao; Zhang, Yanming; Sha, Xiaofeng
• Is Part Of: RNA biology. Volume 16:Issue 5(2019)
• Page Start: 601
• Page End: 611
• Publication Date: 2019-05-04
• Subjects: miRNA-disease association prediction -- matrix completion -- Laplacian regularization -- microRNA; RNA -- Periodicals; Molecular biology -- Periodicals; Molecular biology; RNA; Periodicals; 572.8805
• DOI: 10.1080/15476286.2019.1570811
• Languages: English
• ISSNs: 1547-6286

Abstract

ABSTRACT: Since lots of miRNA-disease associations have been verified, it is meaningful to discover more miRNA-disease associations for serving disease diagnosis and prevention of human complex diseases. However, it is not practical to identify potential associations using traditional biological experimental methods since the process is expensive and time consuming. Therefore, it is necessary to develop efficient computational methods to accomplish this task. In this work, we introduced a matrix completion model with dual Laplacian regularization (DLRMC) to infer unknown miRNA-disease associations in heterogeneous omics data. Specifically, DLRMC transformed the task of miRNA-disease association prediction into a matrix completion problem, in which the potential missing entries of the miRNA-disease association matrix were calculated, the missing association can be obtained based on the prediction scores after the completion procedure. Meanwhile, the miRNA functional similarity and the disease semantic similarity were fully exploited to serve the miRNA-disease association matrix completion by using a dual Laplacian regularization term. In the experiments, we conducted global and local Leave-One-Out Cross Validation (LOOCV) and case studies to evaluate the efficacy of DLRMC on the Human miRNA-disease associations dataset obtained from the HMDDv2.0 database. As a result, the AUCs of DLRMC is 0.9174 and 0.8289 in global LOOCV and local LOOCV, respectively, which significantly outperform a variety of previous methods. In addition, in the case studies on four significant diseases related to human health including Colon Neoplasms, Kidney neoplasms, Lymphoma and Prostate neoplasms, 90%, 92%, 92% and 94% out of the top 50 predicted miRNAs has been confirmed, respectively.